• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

厌氧膜生物反应器去除城市污水处理中抗生素磺胺甲恶唑及其生物转化途径。

Removal and biotransformation pathway of antibiotic sulfamethoxazole from municipal wastewater treatment by anaerobic membrane bioreactor.

机构信息

Department of Municipal Engineering, School of Civil Engineering, Guangzhou University, Guangzhou, 510006, China; Water Desalination and Reuse Center, Division of Biological and Environmental Science and Engineering, King Abdullah University of Science and Technology, Thuwal, 23955-6900, Saudi Arabia.

Water Desalination and Reuse Center, Division of Biological and Environmental Science and Engineering, King Abdullah University of Science and Technology, Thuwal, 23955-6900, Saudi Arabia.

出版信息

J Hazard Mater. 2019 Dec 15;380:120894. doi: 10.1016/j.jhazmat.2019.120894. Epub 2019 Jul 13.

DOI:10.1016/j.jhazmat.2019.120894
PMID:31325689
Abstract

A lab-scale mesophilic anaerobic membrane bioreactor (AnMBR) was used to treat synthetic municipal wastewater with variable concentrations of antibiotic Sulfamethoxazole (SMX) and bulk organics in this study. The removal and biotransformation pathway of SMX in the AnMBR were systematically investigated during a 170 d of operation under hydraulic retention time of 1 d. Average SMX removal was 97.1% under feed SMX of 10-1000 μg/L, decreasing to 91.6 and 88.0% under feed SMX of 10,000 and 100,000 μg/L due to the inhibition effects of high SMX loading rate on anaerobic microorganisms. SMX biotransformation followed pseudo-first order reaction kinetics based on SMX removal independent of feed SMX of 10-1000 μg/L during continuous operation and also in a batch test under initial SMX of 100,000 μg/L. According to the identified 7 transformation products (TPs) by gas chromatography-mass spectrometry, the biotransformation pathway of SMX from municipal wastewater treatment via AnMBR was first proposed to consist of 2 primary routes: 1) Butylbenzenesulfonamide without antibiotic toxicity dominated under feed SMX of 10-100 μg/L; 2) Sulfanilamide with much lower antibiotic toxicity than SMX dominated under feed SMX of 1000-100000 μg/L, further transforming to secondary TPs (4-Aminothiophenol, Aniline, Acetylsulfanilamide) and tertiary TPs (4-Acetylaminothiophenol, Acetylaniline).

摘要

本研究采用实验室规模的中温厌氧膜生物反应器(AnMBR),在水力停留时间为 1 天的条件下,处理含有不同浓度抗生素磺胺甲恶唑(SMX)和大量有机物的合成城市废水。在 170 天的运行过程中,系统研究了 AnMBR 中 SMX 的去除和生物转化途径。在进料 SMX 为 10-1000μg/L 的条件下,SMX 的平均去除率为 97.1%,而在进料 SMX 为 10000 和 100000μg/L 的条件下,由于高 SMX 加载率对厌氧微生物的抑制作用,SMX 的去除率分别降低至 91.6%和 88.0%。SMX 的生物转化遵循伪一级反应动力学,与连续运行过程中进料 SMX 为 10-1000μg/L 时的 SMX 去除无关,也与初始 SMX 为 100000μg/L 时的批处理试验一致。根据气相色谱-质谱法鉴定的 7 种转化产物(TPs),首次提出了 AnMBR 处理城市污水中 SMX 的生物转化途径由 2 条主要途径组成:1)在进料 SMX 为 10-100μg/L 时,主要生成无抗生素毒性的丁基苯磺酰胺;2)在进料 SMX 为 1000-100000μg/L 时,主要生成抗生素毒性比 SMX 低得多的磺胺,进一步转化为次级 TPs(4-氨基噻吩酚、苯胺、乙酰磺胺)和三级 TPs(4-乙酰氨基噻吩酚、乙酰苯胺)。

相似文献

1
Removal and biotransformation pathway of antibiotic sulfamethoxazole from municipal wastewater treatment by anaerobic membrane bioreactor.厌氧膜生物反应器去除城市污水处理中抗生素磺胺甲恶唑及其生物转化途径。
J Hazard Mater. 2019 Dec 15;380:120894. doi: 10.1016/j.jhazmat.2019.120894. Epub 2019 Jul 13.
2
Sequential Anaerobic-Aerobic Treatment Enhances Sulfamethoxazole Removal: From Batch Cultures to Observations in a Large-Scale Wastewater Treatment Plant.序批式厌氧-好氧处理强化磺胺甲恶唑去除:从批式培养到大型污水处理厂的观察。
Environ Sci Technol. 2024 Jul 16;58(28):12609-12620. doi: 10.1021/acs.est.4c00368. Epub 2024 Jul 7.
3
Evaluating the application of Microbacterium sp. strain BR1 for the removal of sulfamethoxazole in full-scale membrane bioreactors.评估微杆菌属菌株BR1在全尺寸膜生物反应器中对磺胺甲恶唑的去除应用。
Water Sci Technol. 2015;72(10):1754-61. doi: 10.2166/wst.2015.397.
4
Combination of photo-Fenton and biological SBBR processes for sulfamethoxazole remediation.光芬顿与生物序批式生物膜反应器工艺联合处理磺胺甲恶唑
Water Sci Technol. 2008;58(9):1707-13. doi: 10.2166/wst.2008.532.
5
Bioaugmentation of membrane bioreactor with Achromobacter denitrificans strain PR1 for enhanced sulfamethoxazole removal in wastewater.用无色杆菌(Achromobacter denitrificans)菌株 PR1 对膜生物反应器进行生物强化以增强废水中磺胺甲恶唑的去除
Sci Total Environ. 2019 Jan 15;648:44-55. doi: 10.1016/j.scitotenv.2018.08.100. Epub 2018 Aug 7.
6
Removal of antibiotic sulfamethoxazole by anoxic/anaerobic/oxic granular and suspended activated sludge processes.缺氧/厌氧/好氧颗粒污泥和悬浮活性污泥工艺去除抗生素磺胺甲恶唑。
Bioresour Technol. 2018 Mar;251:151-157. doi: 10.1016/j.biortech.2017.12.021. Epub 2017 Dec 9.
7
Exogenous cofactors for the improvement of bioremoval and biotransformation of sulfamethoxazole by Alcaligenes faecalis.粪产碱杆菌对外源因子的利用对磺胺甲恶唑的生物去除和生物转化的改善。
Sci Total Environ. 2016 Sep 15;565:547-556. doi: 10.1016/j.scitotenv.2016.05.063. Epub 2016 May 17.
8
Influence of sulfamethoxazole on anaerobic digestion: Methanogenesis, degradation mechanism and toxicity evolution.磺胺甲恶唑对厌氧消化的影响:产甲烷作用、降解机制和毒性演变。
J Hazard Mater. 2022 Jun 5;431:128540. doi: 10.1016/j.jhazmat.2022.128540. Epub 2022 Feb 22.
9
Transformation of the antibacterial agent sulfamethoxazole in reactions with chlorine: kinetics, mechanisms, and pathways.抗菌剂磺胺甲恶唑与氯反应中的转化:动力学、机理及途径
Environ Sci Technol. 2004 Nov 1;38(21):5607-15. doi: 10.1021/es035225z.
10
Sulfamethoxazole degradation in anaerobic sulfate-reducing bacteria sludge system.厌氧硫酸盐还原菌污泥体系中磺胺甲恶唑的降解。
Water Res. 2017 Aug 1;119:12-20. doi: 10.1016/j.watres.2017.04.040. Epub 2017 Apr 17.

引用本文的文献

1
Perfluoroalkane Sulfonamides and Derivatives, a Different Class of PFAS: Sorption and Microbial Biotransformation Insights.全氟烷烃磺酰胺及其衍生物,一类不同的全氟和多氟烷基物质:吸附及微生物生物转化研究见解
Environ Sci Technol. 2025 Jun 10;59(22):10734-10749. doi: 10.1021/acs.est.5c00906. Epub 2025 May 25.
2
Anaerobic Membrane Bioreactors for Municipal Wastewater Treatment: A Literature Review.用于城市污水处理的厌氧膜生物反应器:文献综述
Membranes (Basel). 2021 Dec 8;11(12):967. doi: 10.3390/membranes11120967.